has been to provide accurate and useful information on this topic, both for the general population and for professionals, by presenting a diverse and compelling collection of articles that will equip professionals with practical tools and foster interest in sexological science among the public.An essential aspect of science is the availability of reliable and valid measurement tools that allow for accurate assessment of sexological variables in individuals, and this special issue includes three articles on this topic. The article Psychometric Evaluation of the Abbreviated Hungarian Faking Orgasm Scale for Women (Csány et al., 2024) examines the factorial structure of a scale designed to explore the underlying motivation in cases of faked orgasm. The article Development of a Cross-Cultural Scale on Attitudes Toward Gender and Sexual Diversity (AGSD) (Oleas et al., 2025) presents the development of a scale aimed at assessing attitudes toward gender and sexual diversity. This scale constitutes a valuable tool for both clinical and educational contexts, where attitudes toward gender and sexual diversity can be evaluated to promote changes toward healthier attitudes. The third article focused on instrument validation is entitled Validation of the Brief Index of Sexual Functioning for Women and Men (BISF-W and BISF-M) in an Italian Sample (Panzeri et al., 2024). This study validates an assessment instrument originally designed for women and develops a version for men, in its Italian adaptation, to evaluate sexual experiences in both clinical and experimental settings. (Paramio et al., 2024), addresses concerns related to sexual behaviours in young people within non-psychopathological contexts.Overall, this special issue constitutes a highly informative and timely contribution for researchers and clinicians seeking to stay up to date in the field of sexuality and sexual dysfunctions.Cabello-García, M. A., Sánchez-Sandoval, Y., & García-Rojas, A. D. (2024).Influence of personality disorders on sexual behaviours and response to treatment of psychogenic erectile dysfunction in phosphodiesterase 5 inhibitor non-responders.
Olvera et al. (Thu,) studied this question.